Spirobarbital
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
1-ethyl-2,4-dimethyl-7,9-diazaspiro[4.5]decane-6,8,10-trione | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 12262-77-0 |
ATC code | None |
UNII | LR477QH2IL |
Synonyms | 5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid |
Chemical data | |
Formula | C12H18N2O3 |
Mol. mass | 238.282 g/mol |
SMILES
| |
(what is this?) (verify) | |
Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]
References
- ↑ US Patent 2561688
- ↑ Isbell H, Chrusciel TS. Dependence Liability of Non-Narcotic Drugs. Bulletin of the World Health Organisation 1970; 43: Supplement.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.